BIOHERENT

LOGO BIOHERENT

Información de contacto

BIOHERENT
Yara Aceta Piqueras - Product Manager
Calle Severo Ochoa 34
Málaga - 29590
Málaga
+34 625 77 04 49
Áreas de actividad
  • Diagnóstico in vitro
  • Dispositivos médicos
  • Screening
  • Inmunología
  • Oncología
  • Instrumental científico y técnico
  • Nanotecnologías y Biología in silico
  • Sistemas ópticos de láser
Comisiones

Bioherent is a deep-tech SME founded in 2021 as a spin-off from the University of Malaga specialized in the development and manufacturing of advanced biosensor technology for the IVD market. Our mission is to advance drug allergy diagnostics through a novel in-vitro diagnostics technology for accurate identification of drug allergies. We aim to deliver effective, accessible, and fast tests that transform how drug allergies are identified and managed. We pursue this mission by developing advanced biosensors technology based on integrated photonics for the IVD industry.

Productos y servicios

Bioherent will introduce the AllerWAVE™ technology, setting a new benchmark for accuracy, efficiency, and accessibility of drug allergy testing. Our solution is designed to replace a failing technology and outdated methods, ensuring patients receive the right treatment at the right time, without compromise.


AllerWAVE diagnostics speeds up the diagnostic process and makes it safer. We offer two diagnostic panels for near-patient testing as part of a cross-sale strategy: AllerWAVE™ Antibiotics, an all-in-one test for identifying allergic reactions to four key antibiotics, including Amoxicillin and Penicillins, and AllerWAVE™ Anaphylaxis, for detecting acute reactions using a distinct biomarker panel. The Anaphylaxis panel complements the Antibiotics panel by addressing acute allergic reactions often undetected due to differing allergic mechanisms. Paired with our tabletop instrument, these panels provide accurate drug allergy diagnostics and acute reaction detection, supporting up to 13 million people across Europe annually.

Áreas de interés para futuras colaboraciones

Biotecnología, diagnóstico in vitro, enfermedades inmunitarias, diagnóstico de alergia, cuantificación de biomarcadores, nuevos biomarcadores, oncología, fotónica, biosensores, ensayos clínicos, calidad y regulación en la industria IVD, proyectos públicos, financiación privada, kits de diagnóstico, comercialización y desarrollo de negocio.